The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

Esatoglu S. N., Keskin D., EŞKAZAN A. E., ELVERDİ T., SALİHOĞLU A., AR M. C., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.1, pp.348-354, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.3906/sag-2004-282
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.348-354
  • Istanbul University Affiliated: Yes

Abstract

Background/aim: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients.